Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Should You Hold Marsh & McLennan In Your Portfolio?

Published 05/21/2019, 08:02 AM
Updated 07/09/2023, 06:31 AM

Marsh & McLennan Companies, Inc. (NYSE:MMC) is well poised for growth on the back of solid operating performance and inorganic growth.

The company flaunts an encouraging earnings surprise history, having outpaced the Zacks Consensus Estimate in three of the trailing four quarters, the average beat being 3.44%. This trend of consecutive estimate surprises reflects Marsh & McLennan’s operating efficiency.

Its return on equity — a profitability measure — is 29.7%, better than the industry average of 25.8%. Further, the metric reflects the company’s effectiveness in utilizing shareholders’ money.

Marsh & McLennan recently delivered first-quarter 2019 adjusted earnings per share of $1.52, surpassing the Zacks Consensus Estimate by 4.8%. Also, the bottom line improved 10.1% year over year. Moreover, its consolidated revenues were $4.1 billion, up 4% on an underlying basis.

The company’s operating performance has been favorable for the past many years, driven by its diverse product offerings, a wide geographic footprint and strong client retention. Its revenues have been increasing consistently since 2010 (except for in 2015). This favorable trend continued in 2018 and the first quarter of 2019, with the metric rising 6.6% and 4%, respectively, year over year, led by strong segmental growth, acquisitions and foray into new areas etc. Given the company’s initiatives to expand its portfolio, we expect revenues to grow going forward.

Acquisition is one of Marsh and McLennan’s core growth strategies. The company has made numerous purchases within its different operating units that enabled it to enter new geographies, expand within the existing ones, foray into fresh businesses, develop new segments and specialize within its current businesses. It spent $140 million for acquisitions in the first three months of 2019.

The company’s sturdy financial position, backed by a solid balance sheet and a consistent cash flow, also impresses. Its disciplined capital management through share buyback and dividend payments strengthened investors’ confidence in the stock. The company has been repurchasing shares over the past several quarters.

However, its operating expenses escalated over the last several years due to higher compensation and benefits. The same further increased 7.2% and 1.3% during 2018 and the first quarter of 2019, respectively, on account of rise in compensation and benefits plus other operating expenses. A persistent increase in expenses might weigh on the company’s margins.

The Zacks Consensus Estimate for current-year earnings is pegged at $4.61, suggesting an improvement of 5.9% from the year-ago quarter’s number. Meanwhile, the consensus mark for revenues stands at $16.7 billion, indicating 12% growth from the year-ago quarter.

For 2020, the Zacks Consensus Estimate for earnings stands at $5.08, suggesting 10.3% growth from the year-earlier quarter figure. Further, the consensus mark for revenues is pegged at $18.1 billion, implying 7.9% rise from the year-earlier period.

The expected long-term earnings growth rate is 11.8%, above the industry average of 10.7%, which is an upside for the company.

Shares of this Zacks Rank #3 (Hold) company have rallied 17.5% in a year, underperforming its industry’s growth of 21.7%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Stocks to Consider

Investors interested in the insurance industry might look into some better-ranked stocks like eHealth, Inc. (NASDAQ:EHTH) , Brown & Brown, Inc. (NYSE:BRO) and Erie Indemnity Company (NASDAQ:ERIE) .You can see the complete list of today’s Zacks #1 Rank stocks here.

eHealth offers private health insurance exchange services to individuals, families, and small businesses in the United States and China. The company currently sports a Zacks Rank #1 (Strong Buy). It delivered a beat in three of the last four quarters, the average positive surprise being 127.73%.

Brown & Brown sells insurance products in the United States, England, Canada, Bermuda and the Cayman Islands. It presently has a Zacks Rank # 2 (Buy). The company pulled off average trailing four-quarter positive surprise of 4.56%.

Erie Indemnity works as a managing attorney-in-fact for subscribers at the Erie Insurance Exchange in the United States. The company is a Zacks #2 Ranked player. It came up with average four-quarter positive surprise of 8.97%.

Will you retire a millionaire?

One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”

Click to get it free >>



Marsh & McLennan Companies, Inc. (MMC): Free Stock Analysis Report

eHealth, Inc. (EHTH): Free Stock Analysis Report

Erie Indemnity Company (ERIE): Free Stock Analysis Report

Brown & Brown, Inc. (BRO): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.